Octapharma adds Track & Trace software at pharma plant | Automation.com

Octapharma adds Track & Trace software at pharma plant

Octapharma adds Track & Trace software at pharma plant

October 21, 2014 - Octapharma, a manufacturer of human protein products, added the PAS-X Track & Trace Serialization Aggregation solution at their production site in Vienna.

Octapharma has been committed to patient care and medical innovation for over 30 years. Its core business is the development, production and sale of human proteins from human plasma and human cell-lines. Patients in over 100 countries are treated with products in the areas of haematology, immunotherapy and critical care. Octapharma owns five state-of-the-art production facilities in Austria, France, Germany, Sweden and Mexico.

Octapharma employs strict in-process quality control systems to ensure traceability, providing the complete documentation of the origin of all plasma donations, their processing and distribution to countries worldwide. The company requires a flexible and stringently validated system for marking, identifying and tracking their products.

In a first step, PAS-X Track & Trace will be operated in the packaging area for the Chinese market. The serialization data provided by the Chinese authorities are loaded and the used data are reported back. PAS-X Track & Trace is interfaced to the existing PAS-X and exchanges order and stock data with the MES.

It is intended to install Werum's PAS-X Track & Trace at further packaging lines for different target countries in the Vienna site.

About Werum IT Solutions
Werum IT Solutions is the internationally leading supplier of manufacturing execution systems (MES) and manufacturing IT solutions for the pharmaceutical and biopharmaceutical industries. Its out-of-the-box software product PAS-X is used by 17 of the world's top 30 pharmaceutical and biotech companies in more than 700 installations. Founded in 1969, the IT company employs more than 400 people at its headquarters in Lüneburg, Germany, and at nine other locations in Germany, France, Switzerland, the United States, Japan, and Singapore.
 

MORE CASE STUDIES

VIEW ALL

RELATED